Investing.com - aTyr Pharma (NASDAQ:LIFE) reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
aTyr Pharma announced earnings per share of $-0.460 on revenue of $0.00. Analysts polled by Investing.com anticipated EPS of $-0.470 on revenue of $500K.
aTyr Pharma shares are down 53.92% from the beginning of the year, still down 73.26% from its 52 week high of $8.90 set on November 12, 2021.
aTyr Pharma follows other major Healthcare sector earnings this month
aTyr Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar